z-logo
open-access-imgOpen Access
Curing HIV: Seeking to Target and Clear Persistent Infection
Author(s) -
David M. Margolis,
Nancie M. Archin,
Myron S. Cohen,
Joseph J. Eron,
Guido Ferrari,
J. Víctor García,
Cynthia L. Gay,
Nilu Goonetilleke,
Sarah Joseph,
Ronald Swanstrom,
AnneMarie W. Turner,
Angela Wahl
Publication year - 2020
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2020.03.005
Subject(s) - biology , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , pandemic , intensive care medicine , chronic infection , virology , disease , viral load , covid-19 , immune system , medicine , infectious disease (medical specialty)
Human immunodeficiency virus type 1 (HIV-1) infection persists despite years of antiretroviral therapy (ART). To remove the stigma and burden of chronic infection, approaches to eradicate or cure HIV infection are desired. Attempts to augment ART with therapies that reverse viral latency, paired with immunotherapies to clear infection, have advanced into the clinic, but the field is still in its infancy. We review foundational studies and highlight new insights in HIV cure research. Together with advances in ART delivery and HIV prevention strategies, future therapies that clear HIV infection may relieve society of the affliction of the HIV pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom